Showing results (2631-2640 of 4,138) with videos related to

Sort By:
Pageof 414
Human Gene Therapy|June 19, 2008
Abnormal expression of only the CD34 part of a transgenic CD34/herpes simplex virus-thymidine kinase fusion protein is associated with ganciclovir resistanceEmad Bennour, Christophe Ferrand, Jean-Paul Rémy-Martin, et al.
Human Gene Therapy|February 7, 2014
Circumventing antivector immunity: potential use of nonhuman adenoviral vectorsEstrella Lopez-Gordo, Iva I Podgorski, Nicholas Downes, et al.
Human Gene Therapy|May 27, 2008
Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic miceMichela Alessandra Denti, Tania Incitti, Olga Sthandier, et al.
Human Gene Therapy|May 27, 2008
Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe miceRobin J Ziegler, Scott D Bercury, Jonathan Fidler, et al.
Human Gene Therapy|January 6, 2025
Production of Recombinant Adeno-Associated Virus Through High-Cell-Density Transfection of HEK293 Cells Based on Fed-Perfusion CultureZhe Deng, Yan-Ling Lv, Xin-Tao Wang, et al.
Human Gene Therapy|December 26, 2024
Vectorized Human Antibody-Mediated Anti-Eosinophil Gene TherapyMaria Gioulvanidou, Selenay Sarklioglu, Xinlei Chen, et al.
Human Gene Therapy|November 6, 2024
Cyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell DiseaseMirella Mormin, Luc Rigonnot, Anne Chalumeau, et al.
Human Gene Therapy|October 25, 2024
Adeno-Associated Virus Gene Transfer Ameliorates Progression of Skeletal Lesions in Mucopolysaccharidosis IVA MiceAngélica María Herreño-Pachón, Kazuki Sawamoto, Molly Stapleton, et al.
Human Gene Therapy|February 27, 2025
Central Nervous System-Targeted Gene Therapy for the Treatment of Neurocognitive Deficits in Mucopolysaccharidosis Type II MiceGuoqing Chen, Xia Zhan, Xiaolan Gao, et al.
Human Gene Therapy|February 18, 2025
Minimally Humanized Ezh2 Exon-18 Mouse Cell Lines Validate Preclinical CRISPR/Cas9 Approach to Treat Weaver SyndromeWilliam T Gibson, Tess C Lengyell, Andrea J Korecki, et al.
Pageof 414